AdserrHospital & Healthcare PR Agency · Kochi

Surgical robot cost in India: machine prices, running costs and the business case

What hospitals pay for a surgical robot in India, what it costs to run, and what decides whether the numbers work, with every figure's source and date.

By Adserr · Updated · 11 min read · Reviewed for Indian healthcare advertising rules

On this page (11 sections)

Surgical robot cost in India, for a soft-tissue system, runs from around ₹4.5 crore for an Indian-made multi-arm system such as the SSi Mantra to about ₹15 crore for an imported one such as the da Vinci, as Business Standard reported on 15 September 2022. Scroll (11 May 2026) puts a robotic system with console and arms at ₹20 crore and upwards, with annual maintenance of about 5%, roughly ₹1 crore. Instruments, theatre changes and training are extra.

This guide is for hospitals buying a system. Patients comparing procedure prices should ask the hospital for a written estimate and check their policy with the insurance claim calculator.

Figures checked on 15 November 2026.

Adserr, a healthcare-only agency in Kochi, does not sell surgical robots. It can help you compare quotes from manufacturers and their licensed importers and plan the set-up, and if a supplier pays us anything in connection with your purchase, the written quote says so before you decide.

Surgical robot cost in India by system

There is no single robotic surgery machine price in India; each reported figure covers something different.

Examples named in reportsPrice reported in IndiaWhat the price coversSource and date
Imported multi-arm, soft tissueda VinciAbout ₹15 croreNot statedBusiness Standard, 15 Sep 2022
Imported multi-arm, soft tissueNot named₹20 crore and upwards; maintenance about 5% a yearConsole and armsScroll, 11 May 2026
Imported multi-arm, older modelsda Vinci₹8-20 croreExcludes maintenance, according to AIIMS officialsMedbound Times, 15 Sep 2025
Indian multi-arm, soft tissueSSi MantraAround ₹4.5 croreNot statedBusiness Standard, 15 Sep 2022
Imported orthopaedicMako, CORI, VELYS, CUVIS (no price per brand)US$0.6-1.0 million, about ₹5.7-9.4 crore; maintenance about 10% a yearMost commercial systemsJournal of Orthopaedic Case Reports, Mar 2026
Indian orthopaedic (knee)MISSO₹2 crore (maker's claim)Not statedBusiness Standard, 20 Jun 2024
Government purchases of imported systemsda Vinci in two of three reports₹24 crore for one system (2019); nearly ₹28 crore for one (2026); nearly ₹32 crore for "systems", plural (2023)Tenders usually include warranty and maintenance years, so these are not list pricesBusiness Standard/ANI, 2 Nov 2019; The Tribune, 2 Jul 2026; Telangana Today, 7 Nov 2023

Dollar figures are converted at ₹94.20 per US dollar (FBIL reference rate, 13 November 2026). Naming a system here is not a recommendation, and we have no agreement with any maker named on this page.

Ask each supplier for a written quote with GST, warranty years and the yearly service charge after warranty. GST is 5% where the system is classified under heading 9018 (cut from 12% from 22 September 2025, GST Council, 3 September 2025), so check the HSN code on the quote.

Da Vinci robot price in India

The reports in the table do not give model-by-model prices, and Scroll's "₹20 crore and upwards" (11 May 2026) is for "a robotic system", with no maker named. The maker introduced da Vinci 5 in India in September 2026 for "selected hospitals and programs", with no public price (company release, 18 September 2026).

About half of the maker's 2025 placements worldwide (872 of 1,721) were operating leases, including 496 usage-based arrangements (Intuitive, 14 January 2026). Terms in India are not published, so ask whether a lease is offered and what it costs over the system's life.

SSi Mantra price and other Indian-made surgical robots

Business Standard (15 September 2022) reported the SSi Mantra at around ₹4.5 crore, "less than a third" of the da Vinci's price. The maker of MISSO, an Indian knee robot, priced it at ₹2 crore at launch, with consumables of ₹25,000 a surgery against ₹35,000 for other systems, both the maker's claims (Business Standard, 20 June 2024).

We found no public instrument or service prices for Indian systems, so ask for them in the quote.

Orthopaedic robots: Mako, CORI, VELYS, CUVIS and MISSO

An editorial in the Journal of Orthopaedic Case Reports (March 2026) puts most commercial orthopaedic robots at US$0.6-1.0 million, about ₹5.7-9.4 crore at ₹94.20 per US dollar (FBIL reference rate, 13 November 2026), plus about 10% a year in maintenance, pre-operative imaging (typically a CT scan) and single-use instruments such as cutting guides and burrs.

NICE, England's health technology assessor, noted in April 2025 (HTG743) that every orthopaedic system it assessed is a closed system, used only with the maker's implants, and that the implant accounted for most of the per-patient cost. It found robots "more likely to be cost effective in high-volume orthopaedic centres", and its model assumed 250 cases a year. Compare implant prices, not only the robot's.

Robotic surgery set-up cost: theatre, power, CSSD and training

A 2024 public tender by AIIMS Raipur for one robotic surgery system (GTE 161/2024, 28 August 2024) works as a checklist. It asked for:

  • a surgeon console, a four-arm cart, and capability for a second console and a skills simulator
  • instruments and consumables for 250 surgeries, and a rate for about 250 surgeries a year
  • six surgeons trained and certified by the vendor, plus training for OT nurses, technicians and biomedical staff
  • 230 V power within ±5% and an air-conditioned theatre at 22-30 °C
  • CSSD additions: an ultrasonic cleaner with a tank at least 712 mm long, robotic instrument trays and an H2O2 gas-plasma steriliser
  • five years' warranty plus five years' CMC, 98% uptime, spares for 10 years and complaints attended within 8 hours

NICE (HTG742, 17 April 2025) says the whole team needs training on each system, and outcomes are not maximised until the learning curve is complete. In India, manufacturer training sessions last from a day to five days (Scroll, 11 May 2026). Get each item priced in the quote.

Running costs: service contract, instruments per case and staffing

What drives itEvidence (source, date)
Service contract after warrantyA yearly share of the priceAbout 5% a year for soft-tissue systems (Scroll, 11 May 2026); about 10% for orthopaedic robots (Journal of Orthopaedic Case Reports, Mar 2026); NHSRC advises buying critical equipment with 2 years' warranty plus 8 years' CMC (Jan 2025)
Instruments and accessories per caseProcedure type and the uses each instrument allowsAbout US$1,900 a procedure worldwide, about ₹1.8 lakh, derived from the maker's 2025 results (14 Jan 2026); US$1,866 in 2017, with most instruments limited to about 10 uses (JAMA, 2018); patients pay ₹1-1.5 lakh more than for open surgery because of instruments, according to doctors (Business Standard, 6 May 2022)
Extra theatre timeDocking and the procedureVentral hernia trial: 141 v 77 minutes, robotic v laparoscopic (BMJ, 2020)
Training and staffingA trained team kept together on the rosterSix surgeons plus OT and biomedical staff (2024 tender above); whole-team training (NICE, Apr 2025)
CurrencyDollar pricingA US$1 million system is about ₹9.4 crore before duties

The US$1,900 is a global average: the maker's 2025 instrument and accessory revenue divided by its da Vinci procedures, slightly high because that revenue also covers its Ion system. Conversions use ₹94.20 per US dollar (FBIL reference rate, 13 November 2026).

The business case: clinically indicated volume, length of stay, demand and insurance

Robot-assisted surgery usually raises the cost of each case. NICE (HTG742, 17 April 2025) estimated that robot-assisted soft-tissue surgery increases healthcare costs, "driven by the upfront cost of the robot and additional consumable equipment", with short-term savings "not considered likely to outweigh" them; results were more favourable when the robot replaced open rather than keyhole surgery. A review of 50 randomised trials found "no clear advantage with existing robotic platforms, which are costly and increase operative duration" (Annals of Internal Medicine, 2021). In a ventral hernia trial, robotic repair saved no hospital days and cost 21% more, an adjusted difference of US$2,767 (BMJ, 2020).

Against open surgery, stays can fall: 2.2 more days alive and out of hospital in 90 days after robotic bladder-cancer surgery (JAMA, 2022), and about 1.7 days shorter after robotic prostatectomy, from one trial (Cochrane review, 2017).

Volume decides most of the rest. A 2026 study puts published break-even thresholds at 120-300 cases a year and calls volume "the dominant determinant" (Journal of Robotic Surgery, 2026); another study put it at 349 a year (Surgical Endoscopy, 2016), and a Japanese general hospital lost money per robotic case at low volume (Surgery Today, 2026).

A worked example

The table spreads the price over a 7-year life at a 10% cost of money (about 20.5% of the price a year) and adds the service contract from year 1. These three are assumptions, not sources, and instruments are excluded. For multi-arm systems, 5% is Scroll's maintenance figure and 10% is an assumption borrowed from orthopaedic robots.

Price and maintenanceFixed cost a year100 cases a year200 cases300 cases
Imported multi-arm₹15-20 crore; 5-10%₹3.83-6.11 crore₹3.83-6.11 lakh a case₹1.92-3.05 lakh₹1.28-2.04 lakh
Indian multi-arm₹4.5 crore; 5-10%₹1.15-1.37 crore₹1.15-1.37 lakh₹57,000-69,000₹38,000-46,000
Imported knee robotAbout ₹5.7-9.4 crore; 10%₹1.73-2.88 crore₹1.73-2.88 lakh₹86,000 to ₹1.44 lakh₹58,000-96,000
Indian knee robot₹2 crore; 10%₹61 lakh₹61,000₹31,000₹20,000

Then add instruments per case from your quote: about ₹1-1.8 lakh for soft tissue and ₹25,000-35,000 for a knee (the maker's claim). The ₹1 lakh low end is the extra doctors say patients pay because of instruments (Business Standard, 6 May 2022), not an audited instrument cost.

Reading the table: if patients pay about ₹1-1.5 lakh extra and instruments cost ₹1-1.8 lakh, little or nothing is left to cover the fixed cost, which matches NICE. Hospitals that make the numbers work do it with volume from existing clinical need, cheaper capital (an Indian system, or a lease where offered), negotiated consumables and a case mix that replaces open surgery. Theatre lists matter too: see AI for operation theatre scheduling.

Count only cases your surgeons already expect from current clinical need, never cases promotion might bring. Try your own quote in the cost and savings estimator, and read why hospitals are investing now, with the case for waiting.

Insurance cover for robotic surgery: what it means for a hospital's case volume

IRDAI's exclusions guidelines of 27 September 2019 list robotic surgeries among treatments that "shall not be excluded" and are covered "wherever medically indicated", adding that "sub-limits may be imposed". Its master circular of 29 May 2024 says insurers "shall endeavour to cover" them and replaced a list of earlier circulars, so check current policy wording.

Policies cap it in practice: Mint (14 November 2024) reported caps such as 25% of the sum insured and ₹1 lakh a procedure, while some products pay up to the full sum insured; an insurance broker quoted by Scroll (11 May 2026) said most insurers cap robotic procedures at 50%. One plan in NORKA Care's published terms caps robotic surgery at 50% of the sum insured, up to ₹5 lakh.

We could not confirm any PM-JAY or KASP package for robotic surgery; ask the scheme desk. So payer mix limits volume: count the clinically indicated cases whose cover, or the patient, can meet the robotic charge.

Announcing a surgical robot within the NMC rules

The NMC's guidelines of 6 October 2026 allow factual equipment news without superiority, guaranteed outcomes or comparisons (Explanation II), with:

  • no surgery counts, success rates or "first" claims (8.1(iii), 8.3(ii))
  • no doctor giving an endorsement or statement about the robot or its brand for publicity (8.1(iv))
  • live surgery broadcast only within the NMC's framework for it (7.5)
  • no free surgeries, discounts or similar inducements at a launch (8.1(x))

Our clause-by-clause guide to the NMC's October 2026 rules explains each point, and how to plan a factual launch for a new robot covers the event and staff orientation.

Sources

Frequently asked questions

How much does a da Vinci robot cost in India?

Reports put an imported multi-arm system such as the da Vinci at about ₹15 crore (Business Standard, September 2022), and older models at ₹8-20 crore excluding maintenance, according to AIIMS officials (Medbound Times, September 2025). Scroll (May 2026) puts a system with console and arms at ₹20 crore and upwards. Maintenance, instruments and training are extra.

What is the price of the SSi Mantra?

Business Standard reported it at around ₹4.5 crore in September 2022, less than a third of the da Vinci's price then. Instrument and service prices were not published, so ask for them in the quote.

What does it cost to set up robotic surgery in a hospital?

In addition to the system, budget for theatre power and air-conditioning, CSSD equipment, team training and a service contract after warranty. We found no public prices for these items, so get each one in the written quote.

How many surgical robots are there in India?

Estimates differ: over 500 in 2025, up from fewer than 100 in 2020 (Clinical Robotic Surgery Association data, reported by Scroll, 11 May 2026), or 600-700 by an SRS India 2026 conference estimate (Outlook, 6 October 2026). Neither is an official count.

Why does robotic surgery cost a hospital more per case?

The robot's price and service contract are fixed costs spread over its cases, and instruments with limited uses add to each case: about ₹1.8 lakh on average worldwide, derived from the maker's 2025 results. Some procedures also take longer in theatre (BMJ, 2020).

Is robotic surgery cheaper than open surgery for the hospital?

Usually not per case. NICE (April 2025) found robot-assisted soft-tissue surgery cost-incurring in the short term, though less so when it replaced open surgery. Shorter stays against open surgery offset part of the cost; the rest depends on volume and what payers pay.

Planning a hospital technology purchase?

Tell us the department, the problem it should solve and your timeline, and we reply with a written scope and a quote: a fixed project fee, never per patient, procedure or case. Visit us opposite Aster Medcity, message us on WhatsApp or email hello@adserr.com.

Discuss your technology project on WhatsApp Call +91 90742 52889